Impact of drug coated balloon on left anterior descending artery stenosis at proximal to myocardial bridge - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effects of Drug-Coated Balloons on Stenosis of the Left Anterior Descending Artery Near Myocardial Bridges

  • By

  • Yuqing Jia

  • Yangfeng Xie

  • Ying Li

  • Huaipeng Zhang

  • Yanfen Li

  • Weiming Li

  • Chuang Li

  • Yixing Yang

  • Wenhao Jia

  • Wenbo Han

  • August 24, 2026

Share

  • 1

    This study investigates drug-coated balloons (DCBs) for treating left anterior descending artery stenosis near myocardial bridges.

  • 2

    A total of 30 patients received DCB treatment, while 105 patients were treated with drug-eluting stents (DES) in this retrospective cohort.

  • 3

    No significant difference in major adverse cardiac events (MACEs) was observed between DCB and DES groups during a median follow-up of 507 days.

  • 4

    Kaplan–Meier analysis showed MACE-free survival rates of 73.96% for DCB and 82.49% for DES, with no statistically significant difference.

  • 5

    The study concludes that DCB does not demonstrate a significant benefit over DES for LAD stenosis proximal to myocardial bridges.

Original Source(s)

Impact of drug coated balloon on left anterior descending artery stenosis at proximal to myocardial bridge

  • by Yuqing Jia, Yangfeng Xie, Ying Li, Huaipeng Zhang, Yanfen Li, Weiming Li, Chuang Li, Yixing Yang, Wenhao Jia, Wenbo Han

  • August 24, 2026

Related Content

Machine learning and conventional Cox regression to predict target-lesion revascularization after percutaneous coronary intervention

Robotic-assisted percutaneous coronary intervention: current evidence and future directions

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.